| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |